Menu
Back to Journals » Cancer Management and Research » Volume 10
Original Research
Can contemporary trials of chemotherapy for HER2-negative metastatic breast cancer detect overall survival benefit?
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 8,544 | Dovepress* | 7,679+ | 619 | 8,298 | |
| PubMed Central* | 865 | 132 | 997 | ||
| Totals | 8,544 | 751 | 9,295 | ||
| *Since 8 November 2018 | |||||
View citations on PubMed Central and Google Scholar